Garodia Chemicals Ltd.
Garodia Chemicals Ltd. Fundamental Analysis
Garodia Chemicals Ltd. (GARODCH.BO) shows weak financial fundamentals with a PE ratio of 26.35, profit margin of 0.00%, and ROE of -1.14%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -101.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze GARODCH.BO's fundamental strength across five key dimensions:
Efficiency Score
ExcellentGARODCH.BO demonstrates superior asset utilization.
Valuation Score
ModerateGARODCH.BO shows balanced valuation metrics.
Growth Score
ModerateGARODCH.BO shows steady but slowing expansion.
Financial Health Score
ModerateGARODCH.BO shows balanced financial health with some risks.
Profitability Score
WeakGARODCH.BO struggles to sustain strong margins.
Key Financial Metrics
Is GARODCH.BO Expensive or Cheap?
P/E Ratio
GARODCH.BO trades at 26.35 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, GARODCH.BO's PEG of 0.02 indicates potential undervaluation.
Price to Book
The market values Garodia Chemicals Ltd. at -136.74 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 12.54 times EBITDA. This signals the market has high growth expectations.
How Well Does GARODCH.BO Make Money?
Net Profit Margin
For every $100 in sales, Garodia Chemicals Ltd. keeps $0.00 as profit after all expenses.
Operating Margin
Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-1.14 in profit for every $100 of shareholder equity.
ROA
Garodia Chemicals Ltd. generates $40.37 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
GARODCH.BO converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
26.35
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.02
vs 25 benchmark
P/B Ratio
Price to book value ratio
-136.74
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.00
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
-1.04
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.50
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-1.14
vs 25 benchmark
ROA
Return on assets percentage
40.37
vs 25 benchmark
ROCE
Return on capital employed
-9.10
vs 25 benchmark
How GARODCH.BO Stacks Against Its Sector Peers
| Metric | GARODCH.BO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 26.35 | 27.18 | Neutral |
| ROE | -114.30% | 860.00% | Weak |
| Net Margin | 0.00% | -121084.00% (disorted) | Weak |
| Debt/Equity | -1.04 | 0.41 | Strong (Low Leverage) |
| Current Ratio | 0.50 | 4.81 | Weak Liquidity |
| ROA | 4036.53% | -7173.00% (disorted) | Strong |
GARODCH.BO outperforms its industry in 2 out of 6 key metrics, particularly excelling in ROA, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Garodia Chemicals Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Cyclical, Commodity, Value
EPS CAGR
N/A
Industry Style: Cyclical, Commodity, Value
FCF CAGR
N/A
Industry Style: Cyclical, Commodity, Value